Identification of Mac-2-binding Protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes

Molecular and Cellular Proteomics

Volumn 9, Issue 4, 2010, Pages 656-666

  Srirajaskanthan, Rajaventhan ^a   Caplin, Martyn E ^a   Waugh, Mark G ^b   Watkins, Jennifer ^a   Meyer, Tim ^a   Justin Hsuan, J ^b   Beaumont, Nicholas J ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ARTICLE; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEUROENDOCRINE TUMOR; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN SECRETION; WESTERN BLOTTING;

EID: 77950682551     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M900401-MCP200     Document Type: Article

References (39)

1. Caplin, M. E., Buscombe, J. R., Hilson, A. J., Jones, A. L., Watkinson, A. F., and Burroughs, A. K. (1998) Carcinoid tumour. Lancet 352, 799-805
2. Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., Moss, S. F., Nilsson, O., Rindi, G., Salazar, R., Ruszniewski, P., and Sundin, A. (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 9, 61-72
3. Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J. N., Rashid, A., and Evans, D. B. (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 26, 3063-3072
4. Gustafsson, B. I., Kidd, M., and Modlin, I. M. (2008) Neuroendocrine tumors of the diffuse neuroendocrine system. Curr. Opin. Oncol. 20, 1-12
5. de Herder, W. W. (2007) Biochemistry of neuroendocrine tumours. Best Pract. Res. Clin. Endocrinol. Metab. 21, 33-41
6. Kaltsas, G., and Grossman, A. B. (2007) Clinical features of gastroenteropancreatic tumours, in Handbook of Neuroendocrine Tumours (Caplin, M. E., and Kvols, L., eds) 1st Ed., pp. 53-82, BioScientifica, Bristol, UK
7. Rindi, G., and Bordi, C. (2005) Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics. Best Pract. Res. Clin. Gastroenterol. 19, 519-534
8. Eriksson, B., Oberg, K., and Stridsberg, M. (2000) Tumor markers in neuroendocrine tumors. Digestion 62, Suppl. 1, 33-38
9. Bast, R. C., Jr., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., and Knapp, R. C. (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Investig. 68, 1331-1337 (Pubitemid 12235035)
10. Balk, S. P., Ko, Y. J., and Bubley, G. J. (2003) Biology of prostate-specific antigen. J. Clin. Oncol. 21, 383-391
11. Kulasingam, V., and Diamandis, E. P. (2007) Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol. Cell. Proteomics 6, 1997-2011 (Pubitemid 350201873)
12. Sardana, G., Marshall, J., and Diamandis, E. P. (2007) Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Clin. Chem. 53, 429-437 (Pubitemid 46447939)
13. Mlynarek, A. M., Balys, R. L., Su, J., Hier, M. P., Black, M. J., and Alaoui-Jamali, M. A. (2007) A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 133, 910-918 (Pubitemid 47437279)
14. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence data-bases using mass spectrometry data. Electrophoresis 20, 3551-3567
15. Park, Y. P., Choi, S. C., Kim, J. H., Song, E. Y., Kim, J. W., Yoon, D. Y., Yeom, Y. I., Lim, J. S., Kim, J. W., Paik, S. G., and Lee, H. G. (2007) Up-regulation of Mac-2 binding protein by hTERT in gastric cancer. Int. J. Cancer 120, 813-820
16. Shah, T., Hochhauser, D., Frow, R., Quaglia, A., Dhillon, A. P., and Caplin, M. E. (2006) Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J. Neuroendocrinol. 18, 355-360
17. Gazdar, A. F., Helman, L. J., Israel, M. A., Russell, E. K., Linnoila, R. I., Mulshine, J. L., Schuller, H. M., and Park, J. G. (1988) Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res. 48, 4078-4082
18. Ono, K., Suzuki, T., Miki, Y., Taniyama, Y., Nakamura, Y., Noda, Y., Watanabe, M., and Sasano, H. (2007) Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727. Anticancer Res. 27, 2231-2239 (Pubitemid 47228058)
19. Parekh, D., Ishizuka, J., Townsend, C. M., Jr., Haber, B., Beauchamp, R. D., Karp, G., Kim, S. W., Rajaraman, S., Greeley, G., Jr., and Thompson, J. C. (1994) Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas 9, 83-90 (Pubitemid 24007355)
20. von Wichert, G., Edenfeld, T., von Blume, J., Krisp, H., Krndija, D., Schmid, H., Oswald, F., Lother, U., Walther, P., Adler, G., and Seufferlein, T. (2008) Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cells. Cell. Signal. 20, 925-934
21. Wegrzyn, J., Lee, J., Neveu, J. M., Lane, W. S., and Hook, V. (2007) Proteomics of neuroendocrine secretory vesicles reveal distinct functional systems for biosynthesis and exocytosis of peptide hormones and neurotransmitters. J. Proteome Res. 6, 1652-1665 (Pubitemid 46814490)
22. Huang, L. J., Chen, S. X., Huang, Y., Luo, W. J., Jiang, H. H., Hu, Q. H., Zhang, P. F., and Yi, H. (2006) Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer. Lung Cancer 54, 87-94
23. Lin, C. Y., Tsui, K. H., Yu, C. C., Yeh, C. W., Chang, P. L., and Yung, B. Y. (2006) Searching cell-secreted proteomes for potential urinary bladder tumor markers. Proteomics 6, 4381-4389 (Pubitemid 44277039)
24. Martin, D. B., Gifford, D. R., Wright, M. E., Keller, A., Yi, E., Goodlett, D. R., Aebersold, R., and Nelson, P. S. (2004) Quantitative proteomic analysis of proteins released by neoplastic prostate epithelium. Cancer Res. 64, 347-355 (Pubitemid 38114117)
25. Wu, C. C., Chien, K. Y., Tsang, N. M., Chang, K. P., Hao, S. P., Tsao, C. H., Chang, Y. S., and Yu, J. S. (2005) Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 5, 3173-3182
26. Grassadonia, A., Tinari, N., Iurisci, I., Piccolo, E., Cumashi, A., Innominato, P., D'Egidio, M., Natoli, C., Piantelli, M., and Iacobelli, S. (2004) 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj. J. 19, 551-556
27. Rindi, G., Licini, L., Necchi, V., Bottarelli, L., Campanini, N., Azzoni, C., Favret, M., Giordano, G., D'Amato, F., Brancia, C., Solcia, E., and Ferri, G. L. (2007) Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development and increase in hyperplasia and neoplasia. J. Clin. Endocrinol. Metab. 92, 2811-2815 (Pubitemid 47037393)
28. Iacobelli, S., Sismondi, P., Giai, M., D'Egidio, M., Tinari, N., Amatetti, C., Di Stefano, P., and Natoli, C. (1994) Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br. J. Cancer 69, 172-176 (Pubitemid 24021843)
29. Marchetti, A., Tinari, N., Buttitta, F., Chella, A., Angeletti, C. A., Sacco, R., Mucilli, F., Ullrich, A., and Iacobelli, S. (2002) Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res. 62, 2535-2539 (Pubitemid 34462731)
30. Zeimet, A. G., Natoli, C., Herold, M., Fuchs, D., Windbichler, G., Daxenbichler, G., Iacobelli, S., Dapunt, O., and Marth, C. (1996) Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer. Int. J. Cancer 68, 34-38 (Pubitemid 26354575)
31. Ozaki, Y., Kontani, K., Hanaoka, J., Chano, T., Teramoto, K., Tezuka, N., Sawai, S., Fujino, S., Yoshiki, T., Okabe, H., and Ohkubo, I. (2002) Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma. Cancer 95, 1954-1962
32. Valentini, A. M., Iacovazzi, P. A., Correale, M., Pirrelli, M., Armentano, R., Iacobelli, S., Tinari, N., Iurisci, I., and Caruso, M. L. (2005) Immunohistochemical and serological 90K/Mac-2BP detection in hepatocellular carcinoma patients: different behaviour of two monoclonal antibodies. Med. Chem. 1, 185-189
33. Iacobelli, S., Bucci, I., D'Egidio, M., Giuliani, C., Natoli, C., Tinari, N., Rubistein, M., and Schlessinger, J. (1993) Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines. FEBS Lett. 319, 59-65 (Pubitemid 23074270)
34. Matarrese, P., Fusco, O., Tinari, N., Natoli, C., Liu, F. T., Semeraro, M. L., Malorni, W., and Iacobelli, S. (2000) Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int. J. Cancer 85, 545-554 (Pubitemid 30075135)
35. Tinari, N., Kuwabara, I., Huflejt, M. E., Shen, P. F., Iacobelli, S., and Liu, F. T. (2001) Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int. J. Cancer 91, 167-172 (Pubitemid 32041735)
36. Inohara, H., Akahani, S., and Raz, A. (1998) Galectin-3 stimulates cell proliferation. Exp. Cell Res. 245, 294-302
37. Inohara, H., and Raz, A. (1995) Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res. 55, 3267-3271
38. Sasaki, T., Brakebusch, C., Engel, J., and Timpl, R. (1998) Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J. 17, 1606-1613 (Pubitemid 28119114)
39. Wang, H., Kachman, M. T., Schwartz, D. R., Cho, K. R., and Lubam, D. M. Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers. Proteomics 2004: 4:2476-2495 (Pubitemid 39025348)